Beijing Foyou Pharma CO.,LTD (SHA:601089)
China · Delayed Price · Currency is CNY 18.14
+1.13 (6.64%)
At close: Aug 20, 2026
SHA:601089 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,581 | 3,504 | 3,446 | 3,340 | 3,240 | 2,838 |
Revenue Growth | 4.57% | 1.71% | 3.17% | 3.07% | 14.18% | 11.93% |
Gross Profit Gross Profit Growth | 2,222 | 2,279 | 2,301 | 2,212 | 2,200 | 1,963 |
Operating Income Operating Income Growth | 392.48 | 492.89 | 472.39 | 481.62 | 432.97 | 354.75 |
Net Income Net Income Growth | 387.69 | 469.36 | 488.67 | 488.77 | 438.9 | 314.47 |
Earnings Per Share EPS Growth | 0.84 | 1.00 | 1.04 | 1.02 | 1.04 | 0.87 |
EPS Growth | -15.37% | -3.85% | 1.96% | -1.92% | 19.54% | 19.18% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Offsets between Segments Offsets between Segments Growth | -2.83 |
Medical Instruments Medical Instruments Growth | 201.97 |
Medicine Medicine Growth | 3,305 |
Total Total Growth | 3,504 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,043 | 2,063 | 2,373 | 2,531 | 2,541 | 534.69 |
Total Debt Total Debt Growth | 17.63 | 25.76 | 75.16 | 124.3 | 122.92 | 137.99 |
Net Cash (Debt) Net Cash Growth | 2,026 | 2,037 | 2,298 | 2,407 | 2,418 | 396.7 |
Net Cash Growth | 1.79% | -11.34% | -4.51% | -0.49% | 509.62% | 67.76% |
Net Cash Per Share Net Cash Per Share Growth | 4.38 | 4.34 | 4.89 | 5.02 | 5.73 | 1.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 399.66 | 360.85 | 690.75 | 555.9 | 659.76 | 528.02 |
Capital Expenditures CapEx Growth | -146.21 | -397.41 | -391.52 | -366.08 | -135.4 | -192.97 |
Free Cash Flow Free Cash Flow Growth | 253.45 | -36.55 | 299.23 | 189.82 | 524.36 | 335.05 |
Free Cash Flow Growth | 351.85% | - | 57.63% | -63.80% | 56.50% | 53.91% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 62.06% | 65.04% | 66.78% | 66.22% | 67.91% | 69.17% |
Operating Margin | 10.96% | 14.06% | 13.71% | 14.42% | 13.36% | 12.50% |
Pretax Margin | 11.80% | 14.93% | 15.68% | 16.44% | 15.00% | 12.89% |
Profit Margin | 10.83% | 13.39% | 14.18% | 14.64% | 13.55% | 11.08% |
FCF Margin | 7.08% | -1.04% | 8.68% | 5.68% | 16.18% | 11.81% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.500 | 0.500 | 0.400 | 0.300 |
Dividend Per Share Growth | 0% | 0% | 0% | 25.00% | 33.33% | 0% |
Dividend Yield | 2.94% | 2.14% | 3.31% | 3.18% | 2.93% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.66 | 23.93 | 15.32 | 16.93 | 16.77 | - |
P/FCF Ratio | 33.50 | - | 25.02 | 43.59 | 14.03 | - |
PS Ratio | 2.37 | 3.21 | 2.17 | 2.48 | 2.27 | - |